Sign in

CIK 0001396814 · Large accelerated filer

Pacira BioSciences, Inc.

Sign in to watch
Ticker
PCRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
510619477
Phone
650-242-8052
Business address
2000 SIERRA POINT PARKWAY, SUITE 900, BRISBANE, CA, 94005
Former names
Pacira Pharmaceuticals, Inc., PACIRA INC, Blue Acquisition Corp
  1. 4 Planned sale Senior Vice President, Finance sold 3,970 shares at $28.72 ($114,018)
  2. 4 Planned sale Chief Medical Officer sold 5,012 shares at $28.57 ($143,193)
  3. 4 Grant or award Director acquired 5,230 shares (grant or award)
  4. 4 Grant or award Director acquired 5,230 shares (grant or award)
  5. 4 Grant or award Chief Financial Officer acquired 12,220 shares (grant or award)
  6. 4 Grant or award Director acquired 5,230 shares (grant or award)
  7. 4 Grant or award Director acquired 5,230 shares (grant or award)
  8. 4 Planned sale Chief Operating Officer sold 1,000 shares at $28.38 ($28,380)
  9. 4 Grant or award Director acquired 5,230 shares (grant or award)
  10. 4 Grant or award Director acquired 5,230 shares (grant or award)
  11. 4 Planned sale Director sold 880 shares at $28.38 ($24,974)
  12. 4 Planned sale Chief Administrative Officer sold 7,452 shares at $28.38 ($211,488)
  13. 4 Grant or award Director acquired 5,230 shares (grant or award)
  14. 4 Grant or award Director acquired 5,230 shares (grant or award)
  15. 4 Shares withheld for taxes Senior Vice President, Finance gave up 1,843 shares (to pay taxes)
  16. 4 Shares withheld for taxes Chief Financial Officer gave up 2,979 shares (to pay taxes)
  17. 4 Shares withheld for taxes Chief Administrative Officer gave up 3,011 shares (to pay taxes)
  18. 4 Shares withheld for taxes Chief Operating Officer gave up 2,754 shares (to pay taxes)
  19. 4 Shares withheld for taxes Chief Medical Officer gave up 1,615 shares (to pay taxes)
  20. 4 Open-market sale Director sold 119,323 shares at an average $30.64 ($3,656,226)

Page 5 of 35 · 695 filings